Navigation Links
Orthofix International Acquires InSWing(TM) Interspinous Process Spacer
Date:10/2/2007

Technology acquisition announced at the opening of Eurospine conference in

Brussels

HUNTERSVILLE, N.C., Oct. 3 /PRNewswire-FirstCall/ -- Orthofix International N.V. (Nasdaq: OFIX) (the Company) today announced it has acquired the rights to all of the intellectual property related to the InSWing(TM) interspinous process spacer.

InSWing is designed to alleviate the leg and back pain suffered by individuals with lumbar spinal stenosis (LSS). The innovative device can be used in a minimally invasive surgical procedure involving minimal or local anesthesia, significantly less blood loss and a shorter rehabilitation period than alternative surgical procedures.

"Our acquisition of the innovative InSWing technology is an important addition to the broad array of products in our spine portfolio. It underscores the Company's continuing commitment to make new minimally invasive devices available to surgeons and advance the treatment of spine conditions for patients around the world," said Orthofix CEO, Alan Milinazzo. "Our initial focus will be to make InSWing available to various international markets that we believe offer the most opportunities for this advanced technology."

InSWing is designed to be placed between the spinous processes of the lumbar spine using a unique unilateral approach. It is secured through the deployment of an innovative double-wing structure resulting in the widening of the spinal canal and decompression of the spinal nerve that was causing the patient's leg and back pain.

InSWing was developed by a team at LFC Sp. Zo.o. that included Dr. Marek Szpalski M.D., Dr. Robert Gunzburg M.D., Ph. D. and Dr. Lechoslaw F. Ciupik, Ph.D., a bioengineer who was the team's chief designer. Dr. Szpalski is Chairman of Orthopedic and Trauma Surgery at the Iris South Teaching Hospitals in Brussels, Belgium, Associate Professor of Orthopedics at New York University, and Deputy Editor of the European Spine Journal. Dr. Gunzburg is an Orthopedic Consultant at the Edith Cavell clinic in Brussels, and is the President-elect of Eurospine as well as Deputy Editor of the European Spine Journal.

Details of the purchase agreement were not disclosed, however Orthofix indicated that current plans include a limited market release of InSWing, which is CE marked, in Europe as early as the end of the fourth quarter of 2007. The Company also indicated that the acquisition is not expected to materially impact financial results for 2007, but is expected to be slightly accretive to earnings in 2008.

About Orthofix International, N.V.

Orthofix International N.V., a global diversified orthopedic products company, offers a broad line of minimally invasive surgical, as well as non- surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages, helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons, hospitals and patients via Orthofix's sales representatives and its subsidiaries, including Breg, Inc. and Blackstone Medical, Inc., and via partnerships with other leading orthopedic product companies including Kendall Healthcare. In addition, Orthofix is collaborating in R&D partnerships with leading medical institutions such as the Orthopedic Research and Education Foundation, the Cleveland Clinic Foundation, and the National Osteoporosis Institute. For more information about Orthofix, please visit http://www.orthofix.com.

Forward-Looking Statements

This news release contains certain forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements concerning expectations related to new products at Orthofix and its subsidiaries, and are based on management's current expectations and estimates and involve risks and uncertainties that could cause actual results or outcomes to differ materially from those contemplated by the forward-looking statements. Factors that could cause or contribute to such differences may include, but are not limited to, unanticipated expenditures, changing relationships with customers, suppliers and strategic partners, risks relating to the protection of intellectual property, changes to the reimbursement policies of third parties, changes to governmental regulation of medical devices, the impact of competitive products, changes to the competitive environment, the acceptance of new products in the market, conditions of the orthopedic industry and the economy and other factors described in the most recent report on Form 10-K and other periodic reports filed by Orthofix with the Securities and Exchange Commission.


'/>"/>
SOURCE Orthofix International N.V.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. International Rating System To Be Introduced For Hospitals In India
11. John Mendelsohn M.D, chosen for an International Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot ... of defective respirators, according to court documents and SEC filings. A jury ... Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... -- Cirujanos holandeses han puesto en marcha ... a compartir sus mejores prácticas por el mundo y ... de Europa, África, Asia y ... que combina la transmisión en vivo con mensajería instantánea ... Educación   "Imagine un médico de Medicines sans ...
(Date:5/24/2016)... -- Diana Russell suffers from a form of rheumatoid arthritis ... This disease has put her in a wheelchair, and ... to leave her home.  Because of the size and ... wheelchair.  So if there is a family function, the ... to wait for the bus. Photo - ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
Breaking Medicine Technology: